跳至主要内容
临床试验/CTRI/2023/01/048951
CTRI/2023/01/048951尚未招募未知

Comparative efficacy of Sildenafil and Tadalafil in persons with erectile dysfunction

ot applicable0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
ot applicable

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Diagnosed with erectile dysfunction as per the ICD-11 criteria.
  • 2.Participants willing to provide informed written consent for participation.
  • 3.Participants in the age group of 21-50 years
  • 4.Participants with adequate literacy to complete the diary card and questionnaires evaluation.
  • 5.Participants must be staying with his spouse for a minimum period of six months and anticipate having the same adult female sexual partner during the study.
  • 6.Participants must not have received Sildenafil or Tadalafil in the past one month.

排除标准

  • 1.Participants taking organic nitrates for any reason.
  • 2.Participants having a history of unstable angina,cardiac stents,or life threatening arrythmias.
  • 3.Participants with a history of primary hypoactive sexual desire disorder.
  • 4.Erectile dysfunction due to spinal cord injury.
  • 5.Any clinical history of structural deformity causing erectile dysfunction.
  • 6.Participants with a history of undergoing prostate surgery e.g. radical prostatectomy.
  • 7.Participants with a clinical history of treated or untreated hypogonadism.
  • 8.Participants with below normal serum testosterone levels.
  • 9.Participants with a major co-morbid mental illness (i.e. schizophrenia and bipolar
  • 10.Participants with a history of hypersensitivity or allergy to Sildenafil or Tadalafil.

研究者

发起方
ot applicable

相似试验